PAVmed (PAVM) Depreciation & Amortization (CF) (2016 - 2025)
PAVmed (PAVM) posted quarterly Depreciation & Amortization (CF) of $18000.0 for Q4 2025, down 73.91% year-over-year from $69000.0 in Q4 2024, and down 18.18% quarter-over-quarter from $22000.0 in Q3 2025.
PAVmed (PAVM) Depreciation & Amortization (CF) (2016 - 2025) Analysis & Trends
PAVmed's Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $18000.0 for Q4 2025.
- In Q4 2025, Depreciation & Amortization (CF) fell 73.91% year-over-year to $18000.0; the TTM figure through Dec 2025 stood at $105000.0 (down 89.06% YoY), while the FY2025 annual figure was $105000.0, down 91.24% from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 stood at $18000.0, down from $22000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $815000.0 in Q2 2022, with the low at $10000.0 in Q2 2021.
- The 5-year median for Depreciation & Amortization (CF) is $216000.0 (2022), against an average of $351263.2.
- The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) surged 8050.0% in 2022, then slumped 92.79% in 2025.
- PAVmed's Depreciation & Amortization (CF) stood at $166000.0 in 2021, then jumped by 337.35% to $726000.0 in 2022, then retreated by 0.14% to $725000.0 in 2023, then sank by 90.48% to $69000.0 in 2024, then slumped by 73.91% to $18000.0 in 2025.
- Business Quant data shows PAVM's Depreciation & Amortization (CF) at $18000.0 in Q4 2025, $22000.0 in Q3 2025, and $22000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 123.80 Mn |
| 10 | PAVmed | 32.48 Mn | 28.69 Mn | -89,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18,000.00 |
| Dec 31, 2025 | 18,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Jun 30, 2024 | 305,000.00 |
| Jun 30, 2024 | 305,000.00 |
| Mar 31, 2024 | 586,000.00 |
| Mar 31, 2024 | 586,000.00 |
| Dec 31, 2023 | 725,000.00 |
| Dec 31, 2023 | 725,000.00 |
| Sep 30, 2023 | 733,000.00 |
| Sep 30, 2023 | 733,000.00 |
| Jun 30, 2023 | 747,000.00 |
| Jun 30, 2023 | 747,000.00 |